FV20 Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

Franklin, C. and Mohr, P. and Meier, F. and Weichenthal, M. and Grimmel-Mann, I. and Gutzmer, R. and Utikal, J. S. and Terheyden, P. and Herbst, R. and Haferkamp, Sebastian and Pföhler, C. and Leiter-Stöppke, U. and Ziller, F. and Meiß, F. and Ulrich, J. and Kreuter, A. and Gebhardt, C. and Welzel, J. and Schilling, B. and Kaatz, M. and Scharfetter-Kochanek, K. and Dippel, E. and Nashan, D. and Sachse, M. M. and Weishaupt, C. and Löffler, H. and Gambichler, T. and Loquai, C. and Heinzerling, L. and Grabbe, S. and Debus, D. and Schley, G. and Weyandt, G. and Trommer, M. and Lodde, G. and Placke, J. M. and Zimmer, L. and Livingstone, E. and Horn, S. and Schadendorf, D. and Ugurel, S. (2022) FV20 Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG. In: 32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Speech)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User:	Petra Gürster
Date Deposited:	12 Oct 2023 09:18
Last Modified:	12 Oct 2023 09:18
URI:	https://pred.uni-regensburg.de/id/eprint/58757

Actions (login required)

View Item